Publisher
Springer International Publishing
Reference18 articles.
1. Petrie KA, Lee WH, Bullock AN, et al. Novel Mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. PLoS One. 2009;4(3):e5005.
2. Classic and atypical fibrodysplasia ossificans progressive (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type 1 receptor ACVR1.
3. Obamuyide HA, Ogunlade SO. A tumour for which surgery will do more harm than good: a case report of fibrodysplasia ossificans progressiva. Niger Postgrad Med J. 2015;22(1):83–8.
4. Kaplan FS, Glaser DL, Pignolo RJ, et al. A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther. 2007;7(5):705–12.
5. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525–7.